Jazz Pharmaceuticals Buys Aerial BioPharma Sleep Drug

Jan 21, 2014

Triangle Business Journal

Morrisville’s Aerial BioPharma sold its sleep drug to Irish drug company Jazz Pharmaceuticals in a deal that could be worth up to nearly $400 million. Jazz paid $125 million up front for a product Aerial has been developing to treat excessive daytime sleepiness in patients with narcolepsy. Jazz is acquiring all of Aerial’s rights, title and interest in and to the product, called ADX-N05, which include patents, clinical data and other rights. Read the full story

Join the discussion

We welcome your thoughtful comments. Please comply with our Community rules.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments